Kc. Chiu et al., GLUCOKINASE GENE IN GESTATIONAL DIABETES-MELLITUS - POPULATION ASSOCIATION STUDY AND MOLECULAR SCANNING, Diabetologia, 37(1), 1994, pp. 104-110
Citations number
39
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
Mutations of the glucokinase gene result in early-onset familial Type
2 (non-insulin-dependent) diabetes mellitus, and several members of th
e mutant glucokinase kindreds were originally diagnosed as having gest
ational diabetes. This study examined the glucokinase gene in 270 Amer
ican Black women, including 94 with gestational diabetes whose diabete
s resolved after pregnancy (gestational diabetes only), 77 with gestat
ional diabetes who developed Type 2 diabetes after pregnancy (overt di
abetes), and 99 normal control subjects who were recruited during the
peripartum period. Two simple sequence repeat polymorphisms flanking e
ither end of the glucokinase gene were evaluated. No association was f
ound between glucokinase alleles and gestational diabetes only or over
t diabetes, after adjustment for multiple comparisons. To detect singl
e base changes, all 11 exons and proximal islet and liver promoter reg
ions were examined by polymerase chain reaction plus single-stranded c
onformational polymorphism analysis in 45 gestational diabetes only pa
tients who had not yet developed Type 2 diabetes. Nine coding region v
ariants were identified: Ala(11) (GCC) to Thr(11) (ACC) in islet exon
1, and 8 variants either in untranslated regions or in the third base
of a codon. Four variant sites were found in introns, but none in spli
cing consensus sequences. Analysis of the promoter regions revealed tw
o common variants, G-->A at islet - 30 (24%), and G-->A at liver - 258
(42%). The frequencies of the promoter variants, determined by allele
specific polymerase chain reaction analysis, did not differ among the
three groups. Thus, no significant coding sequence glucokinase mutati
ons were found in 90 alleles from 45 patients with gestational diabete
s. Further studies will be required to rule out a minor role of the ne
wly-described promoter region variants as susceptibility factors in th
is disorder.